J. Nedelman

发表

Book review: “Bayesian Data Analysis,” Second Edition by A. Gelman, J.B. Carlin, H.S. Stern, and D.B. Rubin Chapman & Hall/CRC, 2004

Jerry Nedelman, J. Nedelman, 2005, Comput. Stat..

Physiologically based pharmacokinetic modeling as a tool for drug development

J. Nedelman, Hitoshi Sato, W. Niederberger, 1995, Journal of pharmacokinetics and biopharmaceutics.

A log-linear model for the Birnbaum-Saunders distribution

James R. Rieck, Jerry R. Nedelman, J. Nedelman, 1991 .

A Log-Linear Model for the Birnbaum-

James R. Rieck, Jerry R. Nedelman, J. Nedelman, 1991 .

Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors

J. Nedelman, S. Mu, R. Capdeville, 2015, European Journal of Clinical Pharmacology.

Utility of Exposure‐Response Analysis in Regulatory Decision on the Selection of Starting Dose of Pasireotide for Cushing Disease

J. Nedelman, N. Mehrotra, Jingyu Yu, 2016, Journal of clinical pharmacology.

Race, socioeconomic status, and the development of end-stage renal disease.

J. Nedelman, R. Luke, C. Byrne, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex

J. Nedelman, N. Coello, Guillaume Baneyx, 2018, Journal of Pharmacokinetics and Pharmacodynamics.

Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.

J. Nedelman, J. McLeod, J. Kalbag, 2001, Diabetes care.

Biostatistics: Statistics in biomedical, public health, and environmental sciences, P.K. Sen (Ed.) (1985), xiii + 519 pp., $60.00

J. Nedelman, 1986 .

Modelling length bias in a longitudinally-linked record system of HIV cases.

J. Nedelman, C. Lawrence, A. Burns, 1991, Statistics in medicine.

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis

J. Nedelman, R. Savic, Marjorie Z Imperial, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid

J. Nedelman, D. Salinger, D. Everitt, 2019, Antimicrobial Agents and Chemotherapy.

Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects

J. Nedelman, D. Everitt, P. Bruinenberg, 2022, Antimicrobial agents and chemotherapy.

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis

J. Nedelman, A. Diacon, R. Dawson, 2020, Antimicrobial Agents and Chemotherapy.

Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors

J. Nedelman, E. Hurh, J. Zhou, 2016, Cancer Chemotherapy and Pharmacology.

Pharmacodynamics of Single Doses of the Novel Immunosuppressant FTY720 in Stable Renal Transplant Patients

J. Nedelman, K. Budde, H. Neumayer, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis

J. Nedelman, D. Salinger, A. del Parigi, 2019, Antimicrobial Agents and Chemotherapy.

P148 Correlating changes in lung function with patient reported outcomes in COPD

J. Nedelman, P. Jones, J. Donohue, 2010, Thorax.

The prevalence of malaria in Garki, Nigeria: double sampling with a fallible expert.

J. Nedelman, 1988, Biometrics.

The Statistical Demography of Whooping Cranes

J. Nedelman, R. Taylor, Jane Thompson, 1987 .

Description of blood pressure changes in patients beginning cyclosporin A therapy.

J. Nedelman, S. Charnick, M. Moore, 1997, Therapeutic drug monitoring.

Pharmacokinetic‐pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly

J. Nedelman, S. Lamberts, H. Schran, 2005, Clinical pharmacology and therapeutics.

A stochastic model for mast cell proliferation in culture

Jerry Nedelman, J. Nedelman, A. Gross, 1985, Journal of cellular physiology.

Population Pharmacokinetics of Subcutaneous Pasireotide in Healthy Volunteers and Cushing’s Disease Patients

J. Nedelman, K. Hu, I. Paule, 2018, Clinical Pharmacokinetics.

Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex

J. Nedelman, N. Coello, Guillaume Baneyx, 2018, Journal of Pharmacokinetics and Pharmacodynamics.

Assessing drug exposure in rodent toxicity studies without satellite animals

J. Nedelman, F. Tse, E. Gibiansky, 1993, Journal of Pharmacokinetics and Biopharmaceutics.

An extension of Satterthwaite's approximation applied to pharmacokinetics.

J. Nedelman, X. Jia, Jerry Nedelman, 1998, Journal of biopharmaceutical statistics.

On the equations of facilitated diffusion

J. Nedelman, 1981 .

Pharmacokinetics and Pharmacodynamics of Multiple‐Dose Terbinafine

J. Nedelman, E. Gibiansky, J. Cramer, 1996, Journal of clinical pharmacology.

The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects.

J. Nedelman, E. Gibiansky, J. Cramer, 1997, Biopharmaceutics & drug disposition.

Applying Bailer's Method for AUC Confidence Intervals to Sparse Sampling

Ekaterina Gibiansky, Jerry R. Nedelman, J. Nedelman, 2004, Pharmaceutical Research.

Male reproductive hormones in patients treated with pretomanid

J. Nedelman, K. Boekelheide, D. Everitt, 2022, The International Journal of Tuberculosis and Lung Disease.

Gametocytemia and Infectiousness in Falciparum Malaria: Observations and Models

J. Nedelman, 1989 .

Introductory review some new thoughts about some old malaria models

Jerry Nedelman, J. Nedelman, 1985 .

Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors

J. Nedelman, S. Mu, R. Capdeville, 2015, European Journal of Clinical Pharmacology.

Quantitative PCR: Procedures and precisions

Patrick J. Heagerty, Jerry Nedelman, C. Lawrence, 1992 .

A negative binomial model for sampling mosquitoes in a malaria survey.

J. Nedelman, 1983, Biometrics.

Inoculation and recovery rates in the malaria model of Dietz, Molineaux, and Thomas

J. Nedelman, 1984 .

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis

J. Nedelman, P. Jones, J. Donohue, 2011, Respiratory research.

Investigation into the experimental kinetic support of the two-state model of the cell cycle

S. I. Rubinow, J. Nedelman, 1980, Cell Biophysics.

Diagnostics for confounding in PK/PD models for oxcarbazepine

D. Rubin, J. Nedelman, L. Sheiner, 2007, Statistics in medicine.

Modeling and Simulation in Clinical Drug Development

Frank Bretz, Jing Yu, Anna Georgieva, 2010 .

The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.

J. Nedelman, J R Nedelman, E Gibiansky, 1996, Journal of pharmaceutical sciences.

Bernoulli Trials, Poisson Trials, Surprising Variances, and Jensen's Inequality

Jerry Nedelman, J. Nedelman, Ted Wallenius, 1986 .

Negative binomial model for mosquitoes.

J. Nedelman, J. Perry, 1984 .

Steady-State Imatinib Trough Levels as Well as Dose Interruptions Are Associated with Clinical Response (CCyR and MMR) and Adverse Events (AEs) in Patients with Chronic Myeloid Leukemia (CML) Receiving IM as Frontline Therapy.

J. Nedelman, R. Larson, M. Baccarani, 2009 .

A Therapeutic Drug Monitoring Algorithm for Refining the Imatinib Trough Level Obtained at Different Sampling Times

J. Nedelman, Y. Chia, F. Mahon, 2009, Therapeutic drug monitoring.

Inference for an age-dependent, multitype branching-process model of mast cells

J. Nedelman, J Nedelman, H Downs, 1987, Journal of mathematical biology.

Facilitated diffusion of oxygen and carbon monoxide in the large affinity regime

S. I. Rubinow, J. Nedelman, 1982 .

Estimation for a model of multiple malaria infections.

J. Nedelman, 1985, Biometrics.

Serial Versus Sparse Sampling in Toxicokinetic Studies

J. Nedelman, F. Tse, 1996, Pharmaceutical Research.

Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis

J. Nedelman, K. Simpson, A. Karara, 1995, Journal of clinical pharmacology.

Bias in the Wagner–Nelson Estimate of the Fraction of Drug Absorbed

J. Nedelman, Yibin Wang, 2002, Pharmaceutical Research.

Application of Sparse Sampling Approaches in Rodent Toxicokinetics: A Prospective View

J. Nedelman, J. Steimer, F. Tse, 1994 .

Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers

J. Nedelman, Mengchun Li, D. Everitt, 2020, Clinical pharmacology in drug development.

Performance of Bailer's Method for AUC Confidence Intervals from Sparse Non-Normally Distributed Drug Concentrations in Toxicokinetic Studies

J. Nedelman, G. Hajian, V. Batra, 1996, Pharmaceutical Research.

On some “disadvantages” of the population approach

Jerry R. Nedelman, J. Nedelman, 2005, The AAPS Journal.

Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling

J. Nedelman, E. Svensson, F. Pappas, 2022, Clinical Pharmacokinetics.

An Exposure-Response Perspective on the Clinical Dose of Pretomanid

J. Nedelman, D. Salinger, Mengchun Li, 2020, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid

J. Nedelman, D. Salinger, D. Everitt, 2019, Antimicrobial Agents and Chemotherapy.

Quantitative PCR with internal controls

Jerry Nedelman, Patrick Heagerty, Charles Lawrence, 1992, Comput. Appl. Biosci..

Daily Dosing for Bedaquiline in Patients with Tuberculosis

J. Nedelman, D. Salinger, M. Spigelman, 2019, Antimicrobial Agents and Chemotherapy.